Jeff Solomon, TD Cowen president, joins 'Money Movers' to discuss markets, the CPI report and current trade negotiations.

Fintel reports that on April 29, 2025, TD Cowen downgraded their outlook for SpringWorks Therapeutics (NasdaqGS:SWTX) from Buy to Hold. Analyst Price Forecast Suggests 60.03% Upside As of April 24, ...

TD Cowen's Doug Creutz doesn't anticipate any mergers between the major studios in 2025, primarily due to regulatory issues ...

Investment bank TD Cowen increased its price target on Advanced Micro Devices, Inc. (AMD) to $115 from $110 and kept a Buy ...

So-called "blank sailings," or canceled voyages to the Port of Los Angeles rose to 17 in May, from just six in the month of April, TD Cowen found. What does the U.S. import from China? There is a ...

TD Cowen analyst Derrick Wood lowered the firm’s price target on Confluent (CFLT) to $34 from $41 and keeps a Buy rating on the shares. The firm said its checks point to a solid 1Q and continued ...

On Tuesday, TD Cowen commenced coverage on Bright Minds Biosciences Inc. (NASDAQ:DRUG) with a Buy rating, indicating a positive outlook for the biotechnology company’s future. The company’s ...

The tariffs are a material issue that will eventually affect the company's financials. TD Cowen predicts that the current ...

Apple "has incentive for Google to appear weaker in search," at least one analyst said Thursday, brushing off the sharp drop ...

The top categories of goods that U.S.-based sellers import from China, and which are most at risk of becoming scarce because ...